Lipid bubbles combined with low-intensity ultrasound enhance the intratumoral accumulation and antitumor effect of pegylated liposomal doxorubicin in vivo

Pegylated liposomal doxorubicin (PLD) is a representative nanomedicine that has improved tumor selectivity and safety profile. However, the therapeutic superiority of PLD over conventional doxorubicin has been reported to be insignificant in clinical medicine. Combination treatment with microbubbles...

Full description

Bibliographic Details
Main Authors: Inoru Yokoe, Daiki Omata, Johan Unga, Ryo Suzuki, Kazuo Maruyama, Yoshiharu Okamoto, Tomohiro Osaki
Format: Article
Language:English
Published: Taylor & Francis Group 2021-01-01
Series:Drug Delivery
Subjects:
Online Access:http://dx.doi.org/10.1080/10717544.2021.1895907
_version_ 1818987166030626816
author Inoru Yokoe
Daiki Omata
Johan Unga
Ryo Suzuki
Kazuo Maruyama
Yoshiharu Okamoto
Tomohiro Osaki
author_facet Inoru Yokoe
Daiki Omata
Johan Unga
Ryo Suzuki
Kazuo Maruyama
Yoshiharu Okamoto
Tomohiro Osaki
author_sort Inoru Yokoe
collection DOAJ
description Pegylated liposomal doxorubicin (PLD) is a representative nanomedicine that has improved tumor selectivity and safety profile. However, the therapeutic superiority of PLD over conventional doxorubicin has been reported to be insignificant in clinical medicine. Combination treatment with microbubbles and ultrasound (US) is a promising strategy for enhancing the antitumor effects of chemotherapeutics by improving drug delivery. Recently, several preclinical studies have shown the drug delivery potential of lipid bubbles (LBs), newly developed monolayer microbubbles, in combination with low-intensity US (LIUS). This study aimed to elucidate whether the combined use of LBs and LIUS enhanced the intratumoral accumulation and antitumor effect of PLD in syngeneic mouse tumor models. Contrast-enhanced US imaging using LBs showed a significant decrease in contrast enhancement after LIUS, indicating that LIUS exposure induced the destruction of LBs in the tumor tissue. A quantitative evaluation revealed that the combined use of LBs and LIUS improved the intratumoral accumulation of PLD. Furthermore, tumor growth was inhibited by combined treatment with PLD, LBs, and LIUS. Therefore, the combined use of LBs and LIUS enhanced the antitumor effect of PLD by increasing its accumulation in the tumor tissue. In conclusion, the present study provides important evidence that the combination of LBs and LIUS is an effective method for enhancing the intratumoral delivery and antitumor effect of PLD in vivo.
first_indexed 2024-12-20T19:02:22Z
format Article
id doaj.art-50dbe3acb5a44f42a24b542ab512aff0
institution Directory Open Access Journal
issn 1071-7544
1521-0464
language English
last_indexed 2024-12-20T19:02:22Z
publishDate 2021-01-01
publisher Taylor & Francis Group
record_format Article
series Drug Delivery
spelling doaj.art-50dbe3acb5a44f42a24b542ab512aff02022-12-21T19:29:22ZengTaylor & Francis GroupDrug Delivery1071-75441521-04642021-01-0128153054110.1080/10717544.2021.18959071895907Lipid bubbles combined with low-intensity ultrasound enhance the intratumoral accumulation and antitumor effect of pegylated liposomal doxorubicin in vivoInoru Yokoe0Daiki Omata1Johan Unga2Ryo Suzuki3Kazuo Maruyama4Yoshiharu Okamoto5Tomohiro Osaki6Faculty of Agriculture, Joint Department of Veterinary Clinical Medicine, Tottori UniversityFaculty of Pharma-Science, Laboratory of Drug and Gene Delivery Research, Teikyo UniversityFaculty of Pharma-Science, Laboratory of Drug and Gene Delivery Research, Teikyo UniversityFaculty of Pharma-Science, Laboratory of Drug and Gene Delivery Research, Teikyo UniversityFaculty of Pharma-Science, Laboratory of Theranostics, Teikyo UniversityFaculty of Agriculture, Joint Department of Veterinary Clinical Medicine, Tottori UniversityFaculty of Agriculture, Joint Department of Veterinary Clinical Medicine, Tottori UniversityPegylated liposomal doxorubicin (PLD) is a representative nanomedicine that has improved tumor selectivity and safety profile. However, the therapeutic superiority of PLD over conventional doxorubicin has been reported to be insignificant in clinical medicine. Combination treatment with microbubbles and ultrasound (US) is a promising strategy for enhancing the antitumor effects of chemotherapeutics by improving drug delivery. Recently, several preclinical studies have shown the drug delivery potential of lipid bubbles (LBs), newly developed monolayer microbubbles, in combination with low-intensity US (LIUS). This study aimed to elucidate whether the combined use of LBs and LIUS enhanced the intratumoral accumulation and antitumor effect of PLD in syngeneic mouse tumor models. Contrast-enhanced US imaging using LBs showed a significant decrease in contrast enhancement after LIUS, indicating that LIUS exposure induced the destruction of LBs in the tumor tissue. A quantitative evaluation revealed that the combined use of LBs and LIUS improved the intratumoral accumulation of PLD. Furthermore, tumor growth was inhibited by combined treatment with PLD, LBs, and LIUS. Therefore, the combined use of LBs and LIUS enhanced the antitumor effect of PLD by increasing its accumulation in the tumor tissue. In conclusion, the present study provides important evidence that the combination of LBs and LIUS is an effective method for enhancing the intratumoral delivery and antitumor effect of PLD in vivo.http://dx.doi.org/10.1080/10717544.2021.1895907pegylated liposomal doxorubicinlipid bubbleslow-intensity ultrasoundsyngeneic mouse tumor modeltumor treatment
spellingShingle Inoru Yokoe
Daiki Omata
Johan Unga
Ryo Suzuki
Kazuo Maruyama
Yoshiharu Okamoto
Tomohiro Osaki
Lipid bubbles combined with low-intensity ultrasound enhance the intratumoral accumulation and antitumor effect of pegylated liposomal doxorubicin in vivo
Drug Delivery
pegylated liposomal doxorubicin
lipid bubbles
low-intensity ultrasound
syngeneic mouse tumor model
tumor treatment
title Lipid bubbles combined with low-intensity ultrasound enhance the intratumoral accumulation and antitumor effect of pegylated liposomal doxorubicin in vivo
title_full Lipid bubbles combined with low-intensity ultrasound enhance the intratumoral accumulation and antitumor effect of pegylated liposomal doxorubicin in vivo
title_fullStr Lipid bubbles combined with low-intensity ultrasound enhance the intratumoral accumulation and antitumor effect of pegylated liposomal doxorubicin in vivo
title_full_unstemmed Lipid bubbles combined with low-intensity ultrasound enhance the intratumoral accumulation and antitumor effect of pegylated liposomal doxorubicin in vivo
title_short Lipid bubbles combined with low-intensity ultrasound enhance the intratumoral accumulation and antitumor effect of pegylated liposomal doxorubicin in vivo
title_sort lipid bubbles combined with low intensity ultrasound enhance the intratumoral accumulation and antitumor effect of pegylated liposomal doxorubicin in vivo
topic pegylated liposomal doxorubicin
lipid bubbles
low-intensity ultrasound
syngeneic mouse tumor model
tumor treatment
url http://dx.doi.org/10.1080/10717544.2021.1895907
work_keys_str_mv AT inoruyokoe lipidbubblescombinedwithlowintensityultrasoundenhancetheintratumoralaccumulationandantitumoreffectofpegylatedliposomaldoxorubicininvivo
AT daikiomata lipidbubblescombinedwithlowintensityultrasoundenhancetheintratumoralaccumulationandantitumoreffectofpegylatedliposomaldoxorubicininvivo
AT johanunga lipidbubblescombinedwithlowintensityultrasoundenhancetheintratumoralaccumulationandantitumoreffectofpegylatedliposomaldoxorubicininvivo
AT ryosuzuki lipidbubblescombinedwithlowintensityultrasoundenhancetheintratumoralaccumulationandantitumoreffectofpegylatedliposomaldoxorubicininvivo
AT kazuomaruyama lipidbubblescombinedwithlowintensityultrasoundenhancetheintratumoralaccumulationandantitumoreffectofpegylatedliposomaldoxorubicininvivo
AT yoshiharuokamoto lipidbubblescombinedwithlowintensityultrasoundenhancetheintratumoralaccumulationandantitumoreffectofpegylatedliposomaldoxorubicininvivo
AT tomohiroosaki lipidbubblescombinedwithlowintensityultrasoundenhancetheintratumoralaccumulationandantitumoreffectofpegylatedliposomaldoxorubicininvivo